company news about FDA Intensifies Crackdown on Unauthorized E-Cigarette Imports Under Import Alert 66-41: What Manufacturers Must Know

The U.S. Food and Drug Administration (FDA) has significantly escalated its enforcement efforts against unauthorized electronic nicotine delivery systems (ENDS) entering the United States. Under Import Alert 66-41, the agency has been detaining shipments of e-cigarette and vaping products that lack the required Premarket Tobacco Product Application (PMTA) marketing authorization, creating substantial compliance challenges for international manufacturers and distributors.

The Scope of Import Alert 66-41

Import Alert 66-41 authorizes FDA field personnel to detain without physical examination any ENDS product that appears to be marketed without the required FDA authorization. Since the September 9, 2020 PMTA deadline, all deemed tobacco products including e-cigarettes, vapes, e-liquids, and related components must receive marketing authorization from FDA before being legally sold or imported into the United States.

Key Enforcement Statistics

Joint Federal Enforcement Task Force

In a landmark development, the FDA partnered with the U.S. Department of Justice (DOJ) and U.S. Marshals Service to form a federal multi-agency task force specifically targeting the illicit e-cigarette supply chain. This task force has conducted high-profile seizure operations at major ports of entry and distribution centers, confiscating millions of unauthorized vaping devices, flavored e-liquids, and disposable e-cigarettes.

Implications for Manufacturers

• PMTA Submission Is Mandatory: Any ENDS product imported into the U.S. must have either a pending PMTA accepted for review or a granted marketing order.
• Flavored Products Face Heightened Scrutiny: FDA has authorized very few flavored ENDS products, primarily tobacco-flavored. Flavored products face an exceptionally high bar for demonstrating net public health benefit.
• Synthetic Nicotine Is Not Exempt: Since the April 2022 legislation, synthetic nicotine products are regulated identically to tobacco-derived nicotine products under FDA CTP authority.
• Nicotine-Free Products May Fall Outside CTP Scope: Products containing no nicotine and no tobacco-derived substances may not be classified as tobacco products, potentially offering a compliant alternative pathway for manufacturers.

Looking Ahead

As FDA continues to tighten enforcement, international manufacturers should carefully evaluate their product classification, ensure full PMTA compliance where applicable, or explore nicotine-free, tobacco-free product alternatives that may operate outside the CTP regulatory framework.